Michael Xiang Selected Research

Michael Xiang Research Topics

Disease

27	Neoplasms (Cancer) 03/2023 - 04/2012
11	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2015
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2014
3	Endometrial Neoplasms (Endometrial Cancer) 07/2021 - 01/2019
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 07/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 05/2020
2	Lung Neoplasms (Lung Cancer) 11/2023 - 12/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2019
2	Adenocarcinoma 05/2020 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2020 - 01/2019
1	Oropharyngeal Neoplasms 10/2023
1	Pneumonia (Pneumonitis) 03/2023
1	Disease Progression 11/2022
1	AIDS-Related Complex (ARC) 07/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Endometrioid Carcinoma 07/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Residual Neoplasm 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Vomiting 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Hypovolemia 01/2019
1	Cytopenia 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Nausea 01/2019
1	Deglutition Disorders (Dysphagia) 12/2018
1	Dermatitis 12/2018
1	Mucositis 12/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2016
1	Multiple Myeloma 10/2016
1	Hematologic Neoplasms (Hematological Malignancy) 05/2014
1	Lymphoma (Lymphomas) 05/2014
1	Leukemia 05/2014
1	Inflammation (Inflammations) 01/2014
1	Wilms Tumor (Wilm's Tumor) 04/2010

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 01/2023 - 12/2021
3	AndrogensIBA 01/2023 - 01/2022
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 12/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 12/2021
2	Protons (Proton)IBA 12/2020 - 01/2020
2	Atovaquone (Mepron)FDA Link 12/2019 - 10/2016
2	Cetuximab (Erbitux)FDA Link 01/2019 - 12/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2016 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 05/2014
1	Prescription DrugsIBA 12/2023
1	osimertinibIBA 03/2023
1	SteroidsIBA 03/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	GalliumIBA 01/2023
1	abirateroneIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	Pyrimethamine (Daraprim)FDA Link 01/2021
1	GlutaminaseIBA 12/2020
1	boldenone undecylenate (Equipoise)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	CytokinesIBA 05/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	STAT5 Transcription FactorIBA 07/2012
1	Pimozide (Orap)FDA Link 07/2012
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2010
1	A-Form DNA (A-DNA)IBA 04/2010

Therapy/Procedure

20	Radiotherapy 11/2023 - 11/2015
12	Therapeutics 12/2023 - 04/2012
9	Drug Therapy (Chemotherapy) 11/2023 - 01/2019
7	Brachytherapy 01/2023 - 11/2015
4	Hysterectomy 07/2021 - 01/2019
3	Neoadjuvant Therapy 10/2023 - 01/2020
2	Chemoradiotherapy 11/2023 - 01/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2020
2	Adjuvant Chemotherapy 07/2021 - 01/2020
1	Immunotherapy 10/2023
1	Adjuvant Radiotherapy 12/2020
1	Proton Therapy 01/2020
1	Conformal Radiotherapy 01/2020
1	Hematopoietic Stem Cell Transplantation 10/2016